Genstar GNT(formerly UroGen)-- an interesting speculation Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Genstar GNT(formerly UroGen)-- an interesting speculation

Public Reply Prvt Reply Mark as Last Read File

Previous 10 PreviousNext

To: Paul Lee who started this subject	2/6/2003 8:37:29 AM
From: Paul Lee	of 100

GenStar Therapeutics and Vascular Genetics Announce Completion of Merger to Form Corautus Genetics SAN DIEGO & ATLANTA--(BUSINESS WIRE)--Feb. 6, 2003--GenStar Therapeutics Corporation (AMEX:GNT) and Vascular Genetics Inc. (VGI) today jointly announced the completion of their merger to form Corautus Genetics Inc., effective as of February 5, 2003. The new combined company will trade on AMEX under the symbol CAQ starting at noon on February 7, 2003. The stockholders of GenStar approved the issuance of common stock in the merger and all other resolutions presented for a vote at GenStar's annual meeting of stockholders held on February 4, 2003. Corautus Genetics was created to capitalize on the complementary strengths of GenStar and VGI to accelerate the development of a later stage genetic therapy for cardiovascular disease. The focus of the company's efforts will be the clinical development of gene therapy products using Vascular Endothelial Growth Factor 2 (VEGF-2), a vascular growth factor gene. CONTACT: Corautus Genetics, Inc. Richard E. Otto, 858/678-0000 Chief Executive Officer SOURCE: GenStar Therapeutics Corporation

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 PreviousNext